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Aims Supravalvar aortic stenosis is a rare form of left ventricular outflow tract obstruction that is often progressive in child-
hood. Little data are available on outcomes in the adult population. Our aim was to define cardiac outcomes in adults
with supravalvar aortic stenosis.
Methods
and results
This is a multicentre retrospective study of cardiac outcomes in adults (≥18 years) with supravalvar aortic stenosis.
We examined: (i) adverse cardiac events (cardiovascular death, myocardial infarction, stroke, heart failure, sustained
arrhythmias, and infective endocarditis) and (ii) the need for cardiac surgery in adulthood. One hundred and thirteen
adults (median age at first visit 19 years; 55% with Williams–Beuren syndrome; 67% with surgical repair in childhood)
were identified. Adults without Williams–Beuren syndrome had more severe supravalvar aortic stenosis and more
often associated left ventricular outflow tract obstructions (P, 0.001). In contrast, mitral valve regurgitation was
more common in patients with Williams–Beuren syndrome. Eighty-five per cent of adults (96/113) had serial
follow-up information (median follow-up 6.0 years). Of these patients, 13% (12/96) had an adverse cardiac event
and 13% (12/96) had cardiac operations (7 valve repair or replacements, 4 supravalvar aortic stenosis repairs, 1
other). Cardiac surgery was more common in adults without Williams–Beuren syndrome (P ¼ 0.007). Progression
of supravalvar aortic stenosis during adulthood was rare.
Conclusion Adults with supravalvar aortic stenosis remain at risk for cardiac complications and reoperations, while progression of
supravalvar aortic stenosis in adulthood is rare. Valve surgery is the most common indication for cardiac surgery in
adulthood.
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Introduction
Supravalvar aortic stenosis is a rare form of left ventricular outflow
tract obstruction. While it may be associated with the Williams–
Beuren syndrome,1 it can also occur as familial disease without fea-
tures of Williams–Beuren syndrome, in conjunction with other
forms of obstructive left ventricular outflow tract lesions or as
an isolated lesion. The supravalvar lesion may involve the entire
aortic root, the coronary arteries, and/or the aortic valve2,3 and
in children it is felt to be a progressive disease,4– 6 perhaps
related to an inadequate growth of the supravalvar aortic root
and the sinotubular junction.4 Children with supravalvar aortic
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stenosis often have early intervention as the supravalvar stenosis is
known to be progressive.7 –11 The clinical course beyond child-
hood, in the operated and unoperated adult, is not well
studied.8,11,12 Therefore, the aim of this study was to examine
late cardiovascular events in adults with supravalvar aortic stenosis
and to identify features associated with increased risk for late car-
diovascular complications. The secondary objective was to investi-
gate progression of the supravalvar obstruction during adulthood.
Methods
Study design and study cohort
This was a multicentre retrospective study of unoperated and repaired
adults (≥18 years of age) with a diagnosis of supravalvar aortic sten-
osis. Adults with an outpatient visit at one of the participating tertiary
adult congenital cardiac clinics were included. The following centres
participated in the study: Toronto Congenital Cardiac Center for
Adults, University Health Network, University of Toronto, Toronto,
Canada; Northern Alberta Adult Congenital Heart Clinic, University
of Alberta Hospital, Edmonton, Canada; McMaster University Adult
Congenital Cardiac Clinic, McMaster University, Hamilton, Canada;
Ottawa Heart Institute Adult Congenital Heart Disease Clinic, Univer-
sity of Ottawa, Canada; German Heart Centre Munich, Technical Uni-
versity Munich, Congenital Heart Disease Clinic, Munich, Germany;
Grown Up Congenital Heart Disease Unit, The Heart Hospital,
London, UK; Adult Congenital Heart Disease Clinic, University Hos-
pital, Basel, Switzerland and Adult Congenital Heart Disease
Program, University Hospital, Zurich, Switzerland. The study was
approved by the institutional ethics boards.
The diagnosis of supravalvar aortic stenosis was documented by
cardiac catheterization, echocardiography, or magnetic resonance
imaging. Supravalvar aortic stenosis was classified as localized when
it was limited to the sinotubular junction and the proximal ascending
aorta. It was classified as diffuse when the narrowing was less circum-
script and also involved the ascending aorta beyond the proximal
portion extending to the aortic arch or the descending aorta. Classifi-
cation was left to the discretion of the treating physician. Patients were
excluded if an echocardiogram was not available as part of their initial
assessment.
Outcomes of interest
When available, serial clinical and echocardiographic data after the
initial presentation to the adult clinic were collected. The primary out-
comes of interest were: (i) adverse cardiovascular events in adulthood
and (ii) the need for cardiac surgery in adulthood. Adverse cardiovas-
cular events were defined as cardiovascular death (specified as sudden
or not sudden), sustained (.30 s) supraventricular or ventricular
arrhythmias, acute coronary syndromes, cerebrovascular events, new
onset heart failure, or infective endocarditis. Secondary outcomes
included: (i) postoperative complications related to prior surgery of
supravalvar stenosis including aneurysms or pseudoaneurysms at the
site of previous patch repair, (ii) echocardiographic evidence of recur-
rent stenosis at the supravalvar level and (iii) progression of supraval-
var aortic stenosis in adulthood.
Data collection
Baseline clinical, electrocardiographic, and echocardiographic data
were obtained by chart review. Baseline clinical variables at the first
clinic visit included: age at first visit, gender, diagnosis of Williams–
Beuren syndrome, details pertaining to other congenital cardiac
lesions specifically those associated with left ventricular outflow tract
obstruction, type of supravalvar aortic stenosis at diagnosis, history
of systemic arterial hypertension, New York Heart Association func-
tional class, medical therapy, and surgical and non-surgical interven-
tions in childhood. Electrocardiographic characteristics included type
of rhythm, the presence of bundle branch block, and QRS duration.
Echocardiographic variables included the supravalvar aortic gradi-
ents, presence and severity of other left ventricular outflow tract
lesions, nature and severity of concomitant valvular lesions, right ven-
tricular outflow tract obstruction, and left ventricular systolic function.
Residual supravalvar aortic stenosis was defined as a peak systolic vel-
ocity .2 m/s (peak systolic gradient of .16 mmHg) at the sinotubular
junction of the ascending aorta. Significant mitral valve disease was
defined as moderate or severe regurgitation and/or stenosis (mean dia-
stolic gradient of .5 mmHg). Significant aortic valve disease was
defined as moderate or severe aortic regurgitation and/or stenosis
(peak systolic velocity .3 m/s).13 To examine echocardiographic pro-
gression of the supravalvar stenosis, we examined the supravalvar gra-
dient at three time points (when available); the last visit in childhood,
the first visit in adulthood, and the last visit in adulthood. Progression
of supravalvar stenosis was defined as an increase in the peak systolic
pressure gradient at the sinotubular junction of the ascending aorta of
.10 mmHg during the serial echocardiograms in adulthood.
Statistical analysis
The statistical analysis was performed using SPSS Version 18 (SPSS,
Inc., Chicago, IL, USA). Continuous variables are reported as either
mean+ SD or median or inter-quartile range (IQR) (25 and 75th per-
centiles) as appropriate. Kaplan–Meier plots were used to depict sur-
vival free from adverse cardiovascular events and cardiac surgery in
adulthood and stratified according to the absence or presence of Wil-
liams–Beuren syndrome. A Cox proportional hazard model was used
to identify determinants of adverse cardiac outcomes and the need for
cardiac surgery in adulthood. Significance of changes in peak supraval-
var systolic gradients between the first clinic visit in adulthood and the
last clinic visit were determined using the Wilcoxon signed-rank test. A
P-value of ,0.05 (two-sided) was considered to be significant.
Results
Baseline characteristics
A total of 113 patients with supravalvar aortic stenosis were iden-
tified. Sixty-two patients (55%) with supravalvar aortic stenosis had
the Williams–Beuren syndrome. Other baseline characteristics are
presented in Tables 1 and 2. Patients without Williams–Beuren
syndrome more commonly had other left-sided outflow tract ob-
structive lesions [22/51 (43%) vs. 2/62 (3%), P, 0.0001] including
aortic valve stenosis (14 patients), subvalvar aortic stenosis (6
patients), and coarctation of the aorta (12 patients). Only two
patients (2%), both without Williams–Beuren syndrome, had a
parachute mitral valve (Shone’s complex, defined as the presence
of multiple levels of left ventricular outflow tract obstruction and
left ventricular inflow obstruction). Seventy-six patients (67%)
had undergone surgical repair of supravalvar aortic stenosis in
childhood. The median age at operation was 7.1 years (IQR:
1.4–11.2). Of those 37 patients who had no operation for supra-
valvar aortic stenosis in childhood, 32 (87%) had Williams–Beuren
syndrome. Those who underwent surgical repair of supravalvar
aortic stenosis in childhood were more likely to have other left
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ventricular outflow tract obstructions (29 vs. 5%, P ¼ 0.004), were
more likely to have moderate or severe aortic valve regurgitation
at the first visit in adulthood (15 vs. 0%, P ¼ 0.015) and were less
likely to have residual supravalvar aortic stenosis at the first visit in
adulthood (36 vs. 65%, P ¼ 0.003). A right bundle branch block at
the first visit in adulthood was more common in patients with
surgery for supravalvar aortic stenosis in childhood (15 vs. 3%,
P ¼ 0.057).
Adults with Williams–Beuren syndrome were less likely to have
additional left ventricular outflow tract obstruction (5 vs. 41%, P,
0.001). Those without the diagnosis of Williams–Beuren syndrome
appeared to have more severe forms of supravalvar aortic stenosis
and more complex left-sided outflow tract disease. In childhood,
they more commonly had undergone surgical repair of supravalvar
aortic stenosis (90 vs. 48%, P, 0.001) and more often had under-
gone multiple surgical procedures (57 vs. 15%, P, 0.0001). At the
first assessment in the adult clinic, they were more likely to have
aortic valve stenosis or regurgitation (33 vs. 3%, P, 0.0001) and
more commonly had a complete right bundle branch block on
their electrocardiogram (18 vs. 5%, P ¼ 0.028). Presentation with
a right bundle branch block on the electrocardiogram was more
common in patients who had multiple cardiac operations in child-
hood (26 vs. 3%, P, 0.0001).
In contrast, mitral valve regurgitation was more common in
adults with Williams–Beuren syndrome. Moderate or severe
mitral valve regurgitation at the first assessment in the adult
clinic was present in four patients (4%); all of whom had
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Table 1 Clinical baseline characteristics of study
patients
Characteristics (n5 113), n (%)
Demographics
Males 77 (68)
Age at first visit in adulthood (years) 19.2 (IQR: 18.5–21.3)
Williams–Beuren syndrome 62 (55)
Cardiac anatomy
Diffuse form of supravalvar aortic stenosis 16 (14)
Involvement of coronary arteries 4 (4)
Documented renal artery stenosis 8 (7)
Documented involvement of aortic
branches other than renal arteries
4 (4)
Involvement of other levels of left
ventricular outflow tract obstruction
24 (21)
Shone’s complex 2 (2)
Surgical history
Surgical repair of supravalvar aortic
stenosis in childhood
76 (67)
Age at repair (years) 7.5 (IQR: 1.7–11.4)
Additional procedures at the time of
repair
30 (27)
More than one cardiac surgery during
childhood
38 (34)
Reoperation for supravalvar aortic
stenosis in childhood
11 (10)
Reoperation for other cardiac lesions in
childhood
19 (17)
Clinical findings at first visit in adulthood
Arterial hypertension 29 (26)
New York Heart Association functional
class ≥ 2
9 (8)
Cardiac medications 36 (33)
Beta-blockers 12 (11)




Angiotensin II receptor antagonists 1 (1)
Diuretics 6 (5)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Electrocardiographic and echocardiographic
baseline characteristics at the first clinic visit in
adulthood
Characteristics (n 5 113*), n (%)
Electrocardiography at first visit in adulthood
Sinus rhythm at presentation in adulthood 111 (98)
Complete left bundle branch block 4 (4)
Complete right bundle branch block 12 (11)
Echocardiography at first visit in adulthood
Native or residual supravalvar aortic
stenosis (peak gradient ≥16 mmHg)
51 (45)
Peak systolic gradient across supravalvar
aortic stenosis
27 (IQR: 20–45)




Bicuspid aortic valve 17 (15)
Aortic stenosis with peak systolic
velocity .3 m/s
11 (10)
More than mild aortic regurgitation 11 (10)
Subvalvar aortic stenosis 2 (2)




Any mitral valve disease 18 (16)
Mitral valve prolapse 14 (12)
Mitral stenosis (mean gradient
≥5 mmHg)
3 (3)
More than mild mitral regurgitation 4 (4)
Right ventricular outflow tract obstruction 3 (3)
Left ventricular ejection fraction (%)* 64+7
Left ventricular fractional shortening (%) 39+8
Left ventricular muscle mass, indexed to
body surface area (g/m2)
93+32
The left ventricular ejection fraction was reported to be normal in 110 patients
(97%), numeric values were available in 72 patients (64%). Measurements of left
ventricular fractional shortening were available in 93/113 patients (82%).
Measurements of the left ventricular muscle mass index were available in 83/113
patients (73%).
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Williams–Beuren syndrome. Significant mitral stenosis at the first
presentation in the adult clinic was present in three patients.
One of the adults with significant mitral stenosis had Williams–
Beuren syndrome and mitral valve repair at the age of 17. The
other two patients were non-syndromic and had dysplastic mitral
valves. Three patients had mild right ventricular outflow tract ob-
struction (peak gradients of 33, 35, and 40 mmHg, respectively).
Adverse cardiovascular events in adults
Serial clinical follow-up information was available in 85% (96/113)
of patients. Of those 17 patients who had only one clinic visit in
adulthood, all had been seen for the first time in the adult clinic
within the last 3 years and were scheduled for regular follow-up
visits in the future. Sixteen patients had just transitioned from
paediatric care and were ,20 years old at the first visit in adult-
hood. Baseline characteristics of patients with clinical follow-up
did not differ from patients without follow up.
The median follow-up duration was 6.0 years (IQR: 2.1–11.4,
range 0.1–30.0) after the initial clinic presentation. The median
age at the last follow-up was 27.3 years (range 18.2–57.9). For
those patients who had surgical resection of supravalvar aortic
stenosis in childhood, the mean follow-up interval after surgery
was 20.7+8.4 years (maximum 42 years).
During the follow-up period, 12 patients (13%) experienced a
total of 20 cardiovascular complications (Table 3). The two deaths
were associated with heart failure in the setting of severe mitral re-
gurgitation. Kaplan–Meier survival curves for late adverse cardio-
vascular events and reoperation are shown in Figure 1.
At the first clinic visit in adulthood, patients with cardiovascular
complications had a higher left ventricular mass (124+ 27 vs.
90+31 g/m2, P ¼ 0.003) and lower left ventricular fractional
shortening (30+8 vs. 40+ 8%, P ¼ 0.001) compared with
those without complications, while left ventricular ejection fraction
was not significantly different (61+ 4 vs. 63+ 7%, P ¼ 0.42).
For patients with new onset heart failure during the follow-up
compared with those without, baseline left ventricular ejection
fraction was not different (59+3 vs. 63+7%, P ¼ 0.20). Of the
seven patients who developed clinical heart failure, three had mod-
erate to severe mitral regurgitation, one had severe tricuspid re-
gurgitation, one had severe aortic regurgitation, and one had
severe supravalvar aortic stenosis. Three patients had an abnormal
left ventricular ejection fraction, including one patient requiring
support by a left ventricular assist device. In all patients with
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Table 3 Cardiovascular outcomes during adulthood in patients with supravalvar aortic stenosis
n5 96 Comments
Adverse cardiovascular events
Any adverse cardiovascular event 20 Median age 28 years (range 19–51)
Cardiovascular death 2 Both deaths were secondary to heart failure
Arrhythmias 8
Atrial flutter or atrial fibrillation 7 Two patients had paroxysmal atrial flutter/fibrillation in
combination with sustained ventricular tachycardia
Sustained ventricular tachycardia 3 One patient had an aborted sudden cardiac death
New onset heart failure 7
Ischaemic stroke 1
Endocarditis 2 Two patients had aortic valve endocarditis
Cardiac surgery
Any cardiac surgery 12 Median age 23 years (range 19–52)
Procedures for supravalvar aortic stenosis
Intervention for restenosis after childhood surgerya 3
Intervention for newly diagnosed severe
supravalvar aortic stenosis 1
Aortic valve procedures
Prosthetic aortic valve replacement 2
Konno procedure 1
Bentall operation 1
Combined aortic and mitral valve procedures
Aortic valve and mitral valve replacement 1
Procedures for right sided heart valves
Tricuspid valve repair 1
Percutaneous pulmonary valve replacement 1
Other procedures
Implantation of left ventricular assist device 1
aIncluding one patient who underwent percutaneous stenting of supravalvar aortic stenosis.
Cardiovascular events and operations are not mutually exclusive.
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abnormal left ventricular ejection fraction, the coronary arteries
were documented to be normal by angiography. Determinants of
adverse cardiovascular events in adulthood are shown in Table 4.
Patients without Williams–Beuren syndrome who experienced
an adverse cardiovascular event more often had additional levels
of left ventricular outflow tract obstructions compared with those
without an event but this did not reach statistical significance (20
vs. 0%, P ¼ 0.083). The rate of reoperations was not different in
patients without Williams–Beuren syndrome with or without add-
itional levels of left ventricular outflow tract obstruction (20 vs.
19%, P ¼ 1.0). Surgical repair of supravalvar aortic stenosis in child-
hood was not associated with cardiovascular complications during
the follow-up in adulthood (HR: 5.5, 95% CI: 0.7–42.9, P ¼ 0.10).
During the follow-up six patients (6%) newly developed echo-
cardiographic evidence of moderate or severe mitral regurgitation;
4/6 (67%) fulfilled diagnostic criteria for mitral valve prolapse. All of
the patients with progressive mitral regurgitation had Williams–
Beuren syndrome. This accounts for 12% of all patients with Wil-
liams–Beuren syndrome for which follow-up data were available.
Two of these patients developed atrial fibrillation and one
patient later died from heart failure.
Cardiac surgery in adults
Twelve patients (13%) underwent cardiac surgery during the
follow-up period (Table 3). Of the 12 reoperations, 6 (50%)
were related to aortic valve disease, including 1 patient with
Figure 1 Survival free of cardiovascular complication and reoperation. Kaplan–Meier plots demonstrating survival free of cardiovascular
complications and reoperation during the follow-up in adults stratified according in those with and without Williams–Beuren syndrome.
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percutaneous pulmonary valve replacement after previous Ross
procedure for aortic valve stenosis. Only two patients with reo-
perations had Williams–Beuren syndrome. Both underwent surgi-
cal repair of supravalvar aortic stenosis (one native stenosis and
one re-stenosis after surgical repair in childhood).
At their first clinic visit in the adult clinic, 51 patients (45%) had
unrepaired or recurrent supravalvar aortic stenosis, including 7
patients with a peak systolic gradient ≥50 mmHg. Four of the
seven patients with significant gradients (≥50 mmHg) at the first
visit to the adult clinic underwent cardiac repair soon after presen-
tation, while the other three patients with significant supravalvar
aortic stenosis gradients are still under observation. Patients with
cardiac surgery in adulthood had a higher left ventricular mass at
the first clinic visit in adulthood compared with those without
(117+ 35 vs. 91+ 31 g/m2, P ¼ 0.019), but left ventricular ejec-
tion fractions were not significantly different (65+ 11 vs. 63+
6%, P ¼ 0.43). Determinants of the need for cardiac surgery in
adulthood are shown in Table 5. In contrast to determinants for
adverse cardiovascular events, neither mitral valve disease at the
first clinic visit (P ¼ 0.739) nor reoperation for supravalvar aortic
stenosis in childhood (P ¼ 1.000) was associated with cardiovascu-
lar surgery during the follow-up in adulthood. As for cardiovascular
complications, the left ventricular mass was a determinant for reo-
perations, but not fractional left ventricular shortening or left ven-
tricular ejection fraction. Surgical repair of supravalvar aortic
stenosis in childhood was not a significant determinant of cardiac
operations during the follow-up in adulthood (HR: 5.2, 95% CI:
0.7–40.2, P ¼ 0.12).
Other postoperative complications
related to prior surgery of supravalvar
stenosis
There were no adults with pseudoaneurysms or aneurysms at the
site of previous patch repair. At their first clinic visit in the adult
clinic, three patients had an enlarged aortic root (maximum
4.5 cm) and one patient had a dilated proximal ascending aorta
(4.7 cm) after a Ross operation. During the follow-up, three add-
itional patients developed dilatation of the proximal ascending
aorta (maximum diameter 4.6 cm); two in the setting of a bicuspid
aortic valve.
Progression of supravalvar aortic stenosis
Of 51 patients with supravalvar aortic stenosis (native stenosis or
re-stenosis) at the first clinic visit in the adult clinic, 4 underwent
surgical repair shortly after presentation. Of the remaining 47
patients, serial echocardiograms were available in 75% of the
patients (n ¼ 35). Figure 2 shows the serial supravalvar gradients
over time. On average, the supravalvar gradients changed little
during the follow-up [median gradient at the first clinic visit
in adulthood 28 mmHg (IQR: 21–47) vs. the median gradient
at the last follow-up in the adult clinic 24 mmHg (IQR: 16–40),
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Table 4 Determinants of adverse cardiovascular events during adulthood in patients with supravalvar aortic stenosis
Hazard ratio 95% Confidence interval P-value
Anatomic variables
Diffuse form of supravalvar aortic stenosis 7.9 2.3–27.6 0.001
Involvement of aortic branches other than renal arteries 3.1 0.9–11.5 0.089
Clinical variables
No diagnosis of Williams–Beuren syndrome 1.7 0.5–5.4 0.373
Reoperation for supravalvar aortic stenosis in childhood 3.9 1.0–15.0 0.051
Multiple cardiac operations in childhood 6.1 1.6–22.6 0.007
NYHA functional class ≥2 9.5 2.5–35.5 0.001
Beta-blocker 4.0 1.0–15.7 0.044
ACE inhibitor 4.2 1.2–14.9 0.027
Electrocardiographic variables
Right bundle branch block 7.3 2.0–25.8 0.002
Echocardiographic variables
Any residual supravalvar aortic stenosis at first clinic visit in adulthood 1.3 0.4–4.5 0.643
Peak systolic gradient of supravalvar aortic stenosis .50 mmHg 1.2 0.2–9.7 0.842
Any haemodynamically significant mitral valve diseasea 7.8 1.6–37.4 0.011
More than mild mitral regurgitation 7.8 1.0–62.8 0.053
Mitral stenosis 6.2 0.8–49.7 0.086
Left ventricular fractional shortening 0.872 0.802–0.948 0.001
Left ventricular ejection fraction 0.956 0.844–1.082 0.48
Left ventricular muscle mass index 1.028 1.010–1.046 0.002
aMore than mild mitral regurgitation or mitral stenosis with mean diastolic pressure gradient .5 mmHg.
Cardiac outcomes in adults with supravalvar aortic stenosis 2447
P ¼ 0.046]. Of those patients without residual supravalvar aortic
stenosis at the first clinic visit in the adult clinic, none had a signifi-
cant increase in peak supravalvar gradients on a serial echocardio-
graphic follow-up. As illustrated in Figure 2, three patients (9%) had
serial increases in the peak supravalvar systolic gradient (increase
from 20 to 35 mmHg, 50 to 70 mmHg and from 70 to
90 mmHg) over a follow-up period of 2.5, 13.7, and 7.0 years.
All three patients remained asymptomatic and none experienced
cardiovascular complications. The patient with a peak systolic
gradient of 90 mmHg at the last clinic visit declined surgical
repair. The patient with an increase in the peak pressure gradient
from 50 to 70 mmHg over a follow-up period of 13.7 years had
serial cardiac magnetic resonance imaging at the last follow-up
and 12 years earlier with morphologically unchanged findings and
a minimal supravalvar aortic diameter of 15 mmHg. No additional
imaging was available in the two other patients.
Discussion
Patients with supravalvar aortic stenosis presenting to adult con-
genital cardiac clinics represent a heterogeneous population. Al-
though supravalvar aortic stenosis can be associated with
Williams–Beuren syndrome, almost half of all adults in our
series had either an isolated form of supravalvar aortic stenosis
or supravalvar aortic stenosis in conjunction with other left ven-
tricular outflow tract obstructive lesions. The associated valvular
cardiac lesions are common and are important determinants of
long-term outcomes in the adult.
Adverse cardiovascular events
Adverse cardiovascular events occurred in .1/10 young adults
(median age 28 years) with supravalvar aortic stenosis, primarily
due to arrhythmias (both atrial and ventricular) and heart failure.
Similar to other surgically repaired congenital lesions, multiple
operations, and subsequent scar tissue may act as a source of
reentry circuits and increase the propensity towards arrhythmias.14
Supravalvar aortic stenosis was not the primary determinant of late
complications. In contrast to the manifestations reported in the
paediatric series, mitral valve disease (regurgitation or stenosis) is
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Table 5 Determinants of cardiac surgery during adulthood in patients with supravalvar aortic stenosis
Hazards ratio 95% Confidence interval P-value
Anatomic variables
Diffuse form of supravalvar aortic stenosis 3.5 0.9–13.5 0.075
Clinical variables
No diagnosis of Williams–Beuren syndrome 6.4 1.4–29.6 0.017
Reoperation for supravalvar aortic stenosis in childhood 1.0 0.1–7.7 1.0
Multiple cardiac operations in childhood 3.8 1.1–12.5 0.030
NYHA functional class ≥2 6.3 1.6–25.7 0.010
Electrocardiographic variables
Right bundle branch block 5.1 1.5–16.9 0.008
Echocardiographic variables
Peak systolic gradient of supravalvar aortic stenosis .50 mmHg 5.2 1.4–19.8 0.015
More than mild aortic regurgitation 3.2 0.9–11.0 0.070
Any haemodynamically significant aortic valve diseasea 2.8 0.8–9.1 0.097
Any significant mitral valve disease at first visit in adulthood 0.7 0.1–5.6 0.739
Left ventricular fractional shortening 0.956 0.881–1.036 0.269
Left ventricular ejection fraction 1.068 0.971–1.175 0.174
Left ventricular muscle mass index 1.019 1.003–1.035 0.018
aAortic stenosis with peak systolic velocity . 3 m/s and/or more than mild aortic regurgitation.
Figure 2 Serial peak systolic gradients at the supravalvar aortic
level. Systolic peak gradients at the supravalvar aortic level at the
last paediatric cardiology visit, first visit in the adult clinic, and last
visit in the adult clinic: each line represents an individual patient
with residual stenosis at the first clinic visit in the adult clinic.
Red lines mark the three patients with an increase in systolic gra-
dients .10 mmHg during the follow-up in adulthood.
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an important determinant of cardiac complications in the adult.
Williams–Beuren syndrome is caused by 7q11.23 deletion and al-
though this region contains a number of genes, the elastin gene is
felt to be the gene responsible for the clinical findings.1 The in-
volvement of the mitral valve, particularly mitral valve prolapse
or regurgitation, in a condition affecting elastin fibres is not surpris-
ing. Indeed, despite a relatively short-follow-up period, progressive
mitral regurgitation was identified in a number of these patients.15
Our findings underscore the need to focus on concomitant valvar
cardiac lesions, particular mitral valve lesions for optimal long-term
care of these patients. Clinical and echocardiographic surveillance
in adults with supravalvar aortic stenosis, even those without
overt valvar heart disease, is important.
In children with supravalvar stenosis, acute coronary syndromes
and sudden cardiac death are well-documented outcomes.16 In our
series, one patient had an aborted sudden death which occurred in
the setting of severe residual supravalvar aortic stenosis, with
normal coronary arteries. No adults presented with acute coron-
ary syndromes. In children, ostial coronary artery lesions are typ-
ically caused by the abnormal growth of the aortic root.2 While
coronary events might have been detected in a larger cohort of
patients or during a longer follow-up period, it may be that the
mechanism responsible for coronary artery obstruction in children
is not present in the adult population. Nonetheless, as this popu-
lation ages, acquired atherosclerotic coronary artery disease may
become more important.17 Residual supravalvar aortic stenosis
may accelerate coronary atherosclerosis as in these patients the
offset of the coronary arteries is proximal to the anatomic narrow-
ing and thus, even in patients without systemic hypertension, cor-
onary arteries face an increased systolic pressure. Long-term
cohort studies will be needed to better define late coronary out-
comes in these patients.
Cardiac surgery
Cardiac surgery during adulthood was required in 1/10 young
adults (median age 23 years) in this study. Cardiac surgeries
varied significantly; one-third of the adults required surgery for
severe recurrent or native supravalvar aortic stenosis and the re-
mainder required surgery for other indications, including left- and
right-sided valve disease. Cardiac surgery was more common in
patients without Williams–Beuren syndrome, likely because of a
higher frequency of associated aortic valve lesions in these patients.
In our cohort, the presence of complete right bundle branch block
was also associated with cardiac operations during adulthood. We
presume that this finding might be a reflection of more previous
cardiac surgery in patients with right bundle branch block and al-
though statistically significant it is less clinically meaningful. Not sur-
prisingly, a high gradient across the ascending aorta was a strong
predictor for cardiac surgery. Continued surveillance for concomi-
tant valve disease, in any position, is important.
Progression of supravalvar aortic stenosis
Progression of supravalvar aortic stenosis may occur in the adult
population, but it is less common than in children. In most
adults, systolic gradients remain stable. This contrasts some
studies in children with supravalvar aortic stenosis, in whom sten-
osis was progressive in up to 80%.4 Differences in the behaviour of
supravalvar obstruction in children and adults may be explained by
the different nature of left ventricular outflow tract obstruction in
these patients. Supravalvar narrowing is typically the consequence
of differential growth of the aortic root during somatic growth and
is not the result of degenerative tissue changes or progressive
tissue ingrowth or hyperplasia.4 Therefore, it seems plausible
that lesions are often progressive during childhood but remain
stable, once growth of the aortic root is completed.
Limitations
This study inherits all limitations of a retrospective design. We
could not ensure standardized clinical and genetic testing for Wil-
liams–Beuren syndrome. The diagnosis of this syndrome was
obtained from available clinic reports and the screening process
for Williams–Beuren syndrome in patients with supravalvar
aortic stenosis may differ between sites. Information on more con-
temporary genetic testing was not performed or available.
There are also limitations with respect to echocardiography.
Measurements of left ventricular ejection fraction, left ventricular
fractional shortening, and left ventricular muscle mass index
were not available in all patients. No established criteria and
thresholds exist for the definition of supravalvar aortic stenosis
and its progression by means of Doppler echocardiography. In
fact, some groups defined the presence and progression as mor-
phologic narrowing at the supravalvar level, without haemodynam-
ic criteria.8 Because no specific criteria are available, the
echocardiographic cut-offs used in this study are therefore arbi-
trary. Furthermore, echocardiographic Doppler gradients may
over- or underestimate the severity of supravalvar aortic stenosis
depending on many factors including the left ventricular systolic
function and the nature of stenosis (tubular vs. discrete).
Our study population was relatively young and therefore, with
ageing of this population, the frequency of complications and the
need for operation may increase. Despite the multicentre efforts
of this study, the number of identified patients with this diagnosis
remains small. To better define outcomes and risk factors, pro-
spective multicentre registries will be needed to identify predictors
for long-term outcomes in patients with this rare cardiac condition.
Conclusions
Adults with supravalvar aortic stenosis remain at risk for cardiac
complications in adulthood. Adverse cardiovascular events are
associated with valve disease, particularly the mitral valve.
Surgery may be needed in some adults with supravalvar aortic
stenosis, but surgical interventions are more commonly required
for valve lesions and not resection of recurrent supravalvar
aortic stenosis.
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